| Year |
Citation |
Score |
| 2024 |
Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, D'Alessandro A, Bartolacci C, Adamczak R, Schmidt L, Wang J, Martines A, Biesiada J, Vest KE, Scaglioni PP, ... Plas DR, et al. Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma. Biorxiv : the Preprint Server For Biology. PMID 38293110 DOI: 10.1101/2024.01.16.575895 |
0.361 |
|
| 2023 |
Shin S, Han MJ, Jedrychowski MP, Zhang Z, Shokat KM, Plas DR, Dephoure N, Yoon SO. mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. Cell Reports. 42: 112868. PMID 37494188 DOI: 10.1016/j.celrep.2023.112868 |
0.316 |
|
| 2023 |
Verma R, Aggarwal P, Bischoff ME, Reigle J, Secic D, Wetzel C, VandenHeuvel K, Biesiada J, Ehmer B, Landero Figueroa JA, Plas DR, Medvedovic M, Meller J, Czyzyk-Krzeska MF. Macrotubule associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cells. The Journal of Biological Chemistry. 104663. PMID 37003503 DOI: 10.1016/j.jbc.2023.104663 |
0.373 |
|
| 2021 |
Czyzyk-Krzeska MF, Meller J, Landero Figueroa JA, Plas DR, Cunningham JT. Metabolic subtypes of clear cell renal cell carcinoma defined by tobacco smoking. Molecular & Cellular Oncology. 8: 1859917. PMID 33860076 DOI: 10.1080/23723556.2020.1859917 |
0.37 |
|
| 2021 |
Wang C, Haas MA, Yeo SK, Paul R, Yang F, Vallabhapurapu S, Qi X, Plas DR, Guan JL. Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis. British Journal of Cancer. PMID 33723393 DOI: 10.1038/s41416-021-01294-0 |
0.435 |
|
| 2019 |
Wang C, Haas MA, Yang F, Yeo S, Okamoto T, Chen S, Wen J, Sarma P, Plas DR, Guan JL. Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells. Nature Metabolism. 1: 1127-1140. PMID 32577608 DOI: 10.1038/s42255-019-0137-5 |
0.364 |
|
| 2018 |
Ennis K, Sarma P, Wetzel C, A. Behrmann C, Plas D. CBMT-16. A COMBINATION STRATEGY TO COUNTERACT PTEN-DEFICIENCY BY TARGETING THE S6 AND TAM KINASES IN GLIOBLASTOMA Neuro-Oncology. 20: vi35-vi35. DOI: 10.1093/Neuonc/Noy148.135 |
0.362 |
|
| 2017 |
Yoon SO, Shin S, Karreth FA, Buel GR, Jedrychowski MP, Plas DR, Dedhar S, Gygi SP, Roux PP, Dephoure N, Blenis J. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition. Molecular Cell. PMID 28757207 DOI: 10.1016/J.Molcel.2017.06.033 |
0.467 |
|
| 2017 |
Li C, Liu X, Liu Y, Zhang E, Medepalli K, Masuda K, Li N, Kopras EJ, Kwiatkowski DJ, Borchers MT, Wikenheiser-Brokamp KA, Osterburg A, Mays M, Sun Y, Plas DR, et al. Tuberin Regulates Prostaglandin Receptor-mediated Viability, via Rheb, in mTORC1-hyperactive Cells. Molecular Cancer Research : McR. PMID 28710231 DOI: 10.1158/1541-7786.Mcr-17-0077 |
0.316 |
|
| 2017 |
Liu H, Feng X, Ennis KN, Behrmann CA, Sarma P, Jiang TT, Kofuji S, Niu L, Stratton Y, Thomas HE, Yoon SO, Sasaki AT, Plas DR. Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia. Cell Reports. 18: 2088-2095. PMID 28249155 DOI: 10.1016/j.celrep.2017.02.022 |
0.41 |
|
| 2016 |
Ghosh J, Kobayashi M, Ramdas B, Chatterjee A, Ma P, Mali RS, Carlesso N, Liu Y, Plas DR, Chan RJ, Kapur R. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance. The Journal of Clinical Investigation. PMID 27294524 DOI: 10.1172/Jci84565 |
0.364 |
|
| 2015 |
Vallabhapurapu SD, Noothi SK, Pullum DA, Lawrie CH, Pallapati R, Potluri V, Kuntzen C, Khan S, Plas DR, Orlowski RZ, Chesi M, Kuehl WM, Bergsagel PL, Karin M, Vallabhapurapu S. Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth. Nature Communications. 6: 8428. PMID 26455434 DOI: 10.1038/ncomms9428 |
0.313 |
|
| 2015 |
Shin S, Buel GR, Wolgamott L, Plas DR, Asara JM, Blenis J, Yoon SO. ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate. Molecular Cell. 59: 382-98. PMID 26190261 DOI: 10.1016/J.Molcel.2015.06.020 |
0.508 |
|
| 2015 |
Ghosh J, Chatterjee A, Ramdas B, Kobayashi M, Ma P, Liu Y, Plas D, Kapur R. S6K1 Regulates Self-Renewal of Leukemia Initiating Cells and Normal Hematopoietic Stem Cells Blood. 126: 442-442. DOI: 10.1182/Blood.V126.23.442.442 |
0.454 |
|
| 2015 |
Ennis K, Feng X, Gallo C, Plas D. ATPS-66INVESTIGATING S6K1 INHIBITORS FOR TARGETING PTEN-DEFICIENT GLIOBLASTOMA Neuro-Oncology. 17: v32.4-v33. DOI: 10.1093/Neuonc/Nov204.66 |
0.412 |
|
| 2014 |
Ghosh J, Ramdas B, Chatterjee A, Ma P, Kobayashi M, Mali R, Liu Y, Plas D, Kapur R. Modulation in the expression of p70S6 kinase impairs the engraftment and self-renewal of hematopoietic stem cells Experimental Hematology. 42: S35. DOI: 10.1182/Blood.V124.21.252.252 |
0.418 |
|
| 2014 |
Ghosh J, Ramdas B, Chatterjee A, Ma P, Kobayashi M, Mali R, Liu Y, Plas DR, Kapur R. Modulation in the Expression of p70S6 Kinase Impairs the Engraftment and Self-Renewal of Hematopoietic Stem Cells Blood. 124: 252-252. DOI: 10.1182/blood.v124.21.252.252 |
0.313 |
|
| 2013 |
Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger JF, Castilla EA, Chen J, Yajima T, Porollo A, Medvedovic M, Brill LM, Plas DR, Riedl SJ, Leitges M, et al. Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis. Cell. 152: 599-611. PMID 23374352 DOI: 10.1016/J.Cell.2012.12.028 |
0.738 |
|
| 2013 |
Barger JF, Gallo CA, Tandon P, Liu H, Sullivan A, Grimes HL, Plas DR. S6K1 determines the metabolic requirements for BCR-ABL survival. Oncogene. 32: 453-61. PMID 22391570 DOI: 10.1038/Onc.2012.70 |
0.727 |
|
| 2011 |
Sommermann TG, O'Neill K, Plas DR, Cahir-McFarland E. IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Research. 71: 7291-300. PMID 21987722 DOI: 10.1158/0008-5472.CAN-11-1715 |
0.445 |
|
| 2011 |
Zhang Y, Johansson E, Miller ML, Jänicke RU, Ferguson DJ, Plas D, Meller J, Anderson MW. Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway. Plos One. 6: e25284. PMID 21980415 DOI: 10.1371/Journal.Pone.0025284 |
0.413 |
|
| 2011 |
Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, Plas DR, Rathmell JC. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. Cancer Research. 71: 5204-13. PMID 21670080 DOI: 10.1158/0008-5472.Can-10-4531 |
0.58 |
|
| 2011 |
Tandon P, Gallo CA, Khatri S, Barger JF, Yepiskoposyan H, Plas DR. Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency. Proceedings of the National Academy of Sciences of the United States of America. 108: 2361-5. PMID 21262837 DOI: 10.1073/Pnas.1013629108 |
0.696 |
|
| 2010 |
Barger JF, Gallo CA, Torni KA, Merk L, Seibel WL, Nelson S, Plas DR. Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycin. Cancer Biology & Therapy. 10: 1256-61. PMID 20935504 DOI: 10.4161/Cbt.10.12.13442 |
0.721 |
|
| 2010 |
Barger JF, Plas DR. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Endocrine-Related Cancer. 17: R287-304. PMID 20699334 DOI: 10.1677/Erc-10-0106 |
0.727 |
|
| 2010 |
Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR. FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. The Journal of Biological Chemistry. 285: 15960-5. PMID 20371605 DOI: 10.1074/jbc.M110.121871 |
0.7 |
|
| 2009 |
Khatri S, Plas DR. Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosis. Cancer Biology & Therapy. 8: 1659-61. PMID 19633429 DOI: 10.4161/Cbt.8.17.9456 |
0.622 |
|
| 2009 |
Plas DR, Thomas G. Tubers and tumors: rapamycin therapy for benign and malignant tumors. Current Opinion in Cell Biology. 21: 230-6. PMID 19237273 DOI: 10.1016/j.ceb.2008.12.013 |
0.416 |
|
| 2005 |
Plas DR, Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene. 24: 7435-42. PMID 16288290 DOI: 10.1038/Sj.Onc.1209097 |
0.547 |
|
| 2005 |
Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Molecular Cell. 18: 283-93. PMID 15866171 DOI: 10.1016/J.Molcel.2005.03.027 |
0.489 |
|
| 2004 |
Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, Rathmell JC, Riley JL, Thompson CB. Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1303-5. PMID 15180958 DOI: 10.1096/Fj.03-1001Fje |
0.357 |
|
| 2004 |
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB. Akt stimulates aerobic glycolysis in cancer cells. Cancer Research. 64: 3892-9. PMID 15172999 DOI: 10.1158/0008-5472.Can-03-2904 |
0.482 |
|
| 2004 |
Arsham AM, Plas DR, Thompson CB, Simon MC. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Research. 64: 3500-7. PMID 15150104 DOI: 10.1158/0008-5472.Can-03-2239 |
0.315 |
|
| 2003 |
Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Molecular and Cellular Biology. 23: 7315-28. PMID 14517300 DOI: 10.1128/Mcb.23.20.7315-7328.2003 |
0.455 |
|
| 2003 |
Karnauskas R, Niu Q, Talapatra S, Plas DR, Greene ME, Crispino JD, Rudin CM. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Oncogene. 22: 688-98. PMID 12569361 DOI: 10.1038/Sj.Onc.1206159 |
0.36 |
|
| 2003 |
Plas DR, Thompson CB. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. The Journal of Biological Chemistry. 278: 12361-6. PMID 12517744 DOI: 10.1074/Jbc.M213069200 |
0.409 |
|
| 2002 |
Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. The CD28 signaling pathway regulates glucose metabolism. Immunity. 16: 769-77. PMID 12121659 DOI: 10.1016/S1074-7613(02)00323-0 |
0.382 |
|
| 2002 |
Plas DR, Rathmell JC, Thompson CB. Homeostatic control of lymphocyte survival: potential origins and implications. Nature Immunology. 3: 515-21. PMID 12032565 DOI: 10.1038/Ni0602-515 |
0.36 |
|
| 2002 |
Arsham AM, Plas DR, Thompson CB, Simon MC. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. The Journal of Biological Chemistry. 277: 15162-70. PMID 11859074 DOI: 10.1074/Jbc.M111162200 |
0.371 |
|
| 2002 |
Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends in Endocrinology and Metabolism: Tem. 13: 75-8. PMID 11854022 DOI: 10.1016/S1043-2760(01)00528-8 |
0.474 |
|
| 2001 |
Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB. Growth factors can influence cell growth and survival through effects on glucose metabolism Molecular and Cellular Biology. 21: 5899-5912. PMID 11486029 DOI: 10.1128/Mcb.21.17.5899-5912.2001 |
0.332 |
|
| 2001 |
Plas DR, Talapatra S, Edinger AL, Rathmell JC, Thompson CB. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. The Journal of Biological Chemistry. 276: 12041-8. PMID 11278698 DOI: 10.1074/Jbc.M010551200 |
0.423 |
|
| 1999 |
Dustin LB, Plas DR, Wong J, Hu YT, Soto C, Chan AC, Thomas ML. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. Journal of Immunology (Baltimore, Md. : 1950). 162: 2717-24. PMID 10072516 |
0.311 |
|
| Show low-probability matches. |